Heart surgery bleeding study seeks best drug dose
NCT ID NCT07164300
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 27 times
Summary
This study looks at different doses of tranexamic acid, a medicine that helps prevent bleeding, in 150 adults having heart surgery with a heart-lung machine. The goal is to find out which dose works best to stop bleeding and reduce the need for blood transfusions. Researchers will take blood samples to measure how long the drug stays active and adjust the dose if needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVERSE DRUG EVENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Ioannina
RECRUITINGIoannina, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.